May 3, 2024
Novo Slides as Obesity Drug Competition Fears Rises
Novo Nordisk A/S shares fell as a US rival’s comments on an experimental obesity drug gave rise to concerns about potential new competition in the rapidly growing field. Novo Nordisk stock fluctuation NovoRead More